EUCTR2007-001509-11-IT进行中（未招募）不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Post-menopausal (for at least 5 years)women 50 years old , ambulatory, capable of understanding the study , having given their written informed consent; diagnosis of osteoporosis: T- score measured by DXA < or =-2.5 at either femoral neck, or the total hip or the lumbar level (L1-L4).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patient who are: unlikely to co-operate in the study, with movement disorders which could intefere during the p-QCT measurement, evolutive cancers during the past 5 years with a risk of bone metastases, BMI less than 18 or higher than 30 Kg/m2. Severe malabsorption. Previous and concomitatn treatment interfering with bone metabolism.
研究者
相似试验
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).EUCTR2007-001509-11-SEInstitut de Recherches Internationales Servier148
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - STRATECPost-menopausal osteoporosisMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2007-001509-11-GRInstitut de Recherches Internationales Servier80
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT). - STRATECEUCTR2007-001509-11-DEInstitut de Recherches Internationales Servier80
进行中（未招募）
不适用
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2g per day of strontium ranelate versus alendronate 70mg per week in women with postmenopausal osteoporosis on bone microarchitecture measured by high resolution peripheral-Quantitative Computed Tomography (p-QCT).EUCTR2006-002732-22-DEInstitut de Recherches Internationales Servier72
进行中（未招募）
不适用
A Clinical Trial to Evaluate the Effects of the drug Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and infection with the bacteria Pseudomonas aeruginosa (AIR-CF4)EUCTR2015-000395-97-Outside-EU/EEAGilead Sciences, Inc.157